Homocysteine and steroids levels in metformin treated women with polycystic ovary syndrome

Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association
J VrbíkováL Stárka

Abstract

Risk for atherosclerosis is increased in women with polycystic ovary syndrome (PCOS). Homocysteine (Hcy) is one of the independent risk factors for ischemic heart disease. We examined the effect of metformin (M) treatment on Hcy levels, steroids and glycide tolerance in PCOS. 9 women with PCOS (defined as hyperandrogenemia and chronic anovulation); age 20 +/- 3.8 yrs, BMI 28.1 +/- 6.5 kg/m(2); examined in the follicular phase of spontaneous menstrual cycle before and after 27 +/- 4 weeks of treatment with M 1000 mg/day. The plasma concentrations of Hcy, DHEA, DHEA-S, cortisol (F), allopregnanolone (HPO), 17OHpregnenolone (17OHPl), insulin (I) and blood glucose (G) before and after the course of M were measured. After the course of M, Hcy significantly increased (10.1 +/- 2.6 to 13.4 +/- 5.1 micromol/l, p < 0.05.). There was no significant change in levels of I, HPO, F, DHEA-S and 17OHPl. DHEA levels increased significantly (from 26.9 +/- 15.7 to 44.4 +/- 24.6 nmol/l, p < 0.05). A borderline significant trend towards reduction in waist-hip ratio was seen (from 0.986 +/- 0.042 to 0.951 +/- 0.085; p < 0.06). Treatment with metformin in women with PCOS can lead to the increase in homocysteine levels--a risk factor for atherosclerosis.

Citations

Jan 9, 2008·Seminars in Reproductive Medicine·Pinar H Kodaman, Antoni J Duleba
Mar 29, 2008·Metabolic Syndrome and Related Disorders·Sunil AsnaniVivian A Fonseca
Jun 2, 2011·Human Reproduction Update·Konstantinos A ToulisBasil C Tarlatzis
Jul 12, 2013·International Journal of Endocrinology and Metabolism·Pietro ScicchitanoMarco Matteo Ciccone
Feb 28, 2009·Journal of Endocrinological Investigation·E Kassi, E Diamanti-Kandarakis
Jul 29, 2011·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Elena E Grodnitskaya, Mark A Kurtser
Jun 1, 2005·Reproductive Biomedicine Online·Sascha TauchertJuergen M Weiss
Aug 15, 2008·Gynécologie, obstétrique & fertilité·T ForgesJ-L Guéant
Sep 9, 2006·Endocrinology and Metabolism Clinics of North America·Preethi SrikanthanSusan Davis
Feb 20, 2007·Human Reproduction Update·Thierry ForgesJ L Guéant
Mar 26, 2010·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Agnieszka LenarcikUrszula Tworowska-Bardzińska
Nov 22, 2019·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Yu SongZhengyan Zhu
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity·Tessa G Lebinger
Jan 13, 2005·Endocrine Journal·Firat BayraktarCandeger Yilmaz
Feb 8, 2003·The Journal of Clinical Endocrinology and Metabolism·Francesco OrioGaetano Lombardi
Aug 22, 2003·Drugs·Ripudaman S Hundal, Silvio E Inzucchi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.